Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Q32 Bio Inc. | 16,363 | reported | 15 Jan 2026 | tx 11+137,746−33,931 |
| Jade Biosciences, Inc. | 12,500 | reported | 05 Jun 2024 | tx 14+10,162,722−7,988,636 |
| Surface Oncology, Inc. | 0 | reported | 08 Sept 2023 | tx 12+3,368,862−13,345,453 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jan 2026 | GRANT_AWARD | Q32 Bio Inc. | 16,363 | 2.75 USD | deriv |
| 23 Oct 2025 | GRANT_AWARD | Q32 Bio Inc. | 53,521 | 0.00 USD | deriv |
| 24 Feb 2025 | OTHER | Q32 Bio Inc. | 2,569 | 0.00 USD | deriv |
| 24 Feb 2025 | OTHER | Q32 Bio Inc. | 18,595 | 0.00 USD | deriv |
| 24 Feb 2025 | OTHER | Q32 Bio Inc. | 12,767 | 0.00 USD | deriv |
| 24 Feb 2025 | GRANT_AWARD | Q32 Bio Inc. | 12,767 | 0.00 USD | deriv |
| 24 Feb 2025 | GRANT_AWARD | Q32 Bio Inc. | 18,595 | 0.00 USD | deriv |
| 24 Feb 2025 | GRANT_AWARD | Q32 Bio Inc. | 2,569 | 0.00 USD | deriv |
| 15 Jan 2025 | GRANT_AWARD | Q32 Bio Inc. | 18,595 | 0.00 USD | deriv |
| 01 Apr 2024 | GRANT_AWARD | Q32 Bio Inc. | 2,569 | 13.42 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Jade Biosciences, Inc. | 12,500 | 0.00 USD | deriv |
| 09 Apr 2024 | SALE | Jade Biosciences, Inc. | 11,882 | 28.15 USD | |
| 25 Mar 2024 | GRANT_AWARD | Q32 Bio Inc. | 12,767 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Jade Biosciences, Inc. | 3,186 | 13.49 USD | deriv |
| 08 Sept 2023 | OTHER | Surface Oncology, Inc. | 2,945,453 | — | |
| 06 Jun 2023 | GRANT_AWARD | Jade Biosciences, Inc. | 12,500 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | Jade Biosciences, Inc. | 2,654 | 18.08 USD | deriv |
| 21 Jun 2022 | GRANT_AWARD | Jade Biosciences, Inc. | 12,500 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Surface Oncology, Inc. | 24,000 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Jade Biosciences, Inc. | 7,317 | 6.56 USD | deriv |
| 02 Jul 2021 | CONVERSION | Jade Biosciences, Inc. | 2,568,165 | — | |
| 02 Jul 2021 | PURCHASE | Jade Biosciences, Inc. | 535,714 | 14.00 USD | first after silence |
| 01 Jul 2021 | GRANT_AWARD | Jade Biosciences, Inc. | 2,153 | 11.15 USD | deriv |
| 02 Jul 2021 | CONVERSION | Jade Biosciences, Inc. | 7,976,754 | — | deriv |
| 01 Feb 2021 | GRANT_AWARD | Jade Biosciences, Inc. | 878,981 | 1.89 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 02 Jul 2021.